| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-04-20 11:39 Tx date 2026-04-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,192
-1,400 vol $2.28 each |
267,221 | |
| Filed 2026-04-20 11:39 Tx date 2026-04-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,442
-4,600 vol $2.27 each |
268,621 | |
| Filed 2026-04-20 11:39 Tx date 2026-04-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,479.84
-16,584 vol $2.26 each |
273,221 | |
| Filed 2026-04-20 11:38 Tx date 2026-04-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,321.80
-2,360 vol $2.25 each |
289,805 | |
| Filed 2026-04-20 11:38 Tx date 2026-04-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,001
-11,556 vol $2.25 each |
292,165 | |
| Filed 2026-01-09 11:07 Tx date 2026-01-08 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,014.72
-448 vol $2.27 each |
303,721 | |
| Filed 2026-01-09 11:07 Tx date 2026-01-08 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,175.52
-13,352 vol $2.26 each |
304,169 | |
| Filed 2026-01-09 11:06 Tx date 2026-01-08 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,267.495
-1,449 vol $2.25 each |
317,521 | |
| Filed 2026-01-09 11:06 Tx date 2026-01-08 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,439.75
-27,751 vol $2.25 each |
318,970 | |
| Filed 2026-01-08 11:21 Tx date 2026-01-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Oliveto, Joseph Gerard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,125
-500 vol $2.25 each |
346,721 | |
| Filed 2025-07-15 22:12 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
53 - Grant of warrants
|
+50,000 vol |
50,000 | |
| Filed 2025-07-15 22:12 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 22:12 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
53 - Grant of warrants
|
+50,000 vol |
50,000 | |
| Filed 2025-07-15 22:12 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 22:11 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,000
+50,000 vol $1.50 each |
50,000 | |
| Filed 2025-07-15 22:11 Tx date 2019-09-09 |
$MIST
Milestone Pharmaceuticals Inc. |
Hasija, Amit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 22:09 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
53 - Grant of warrants
|
+50,000 vol |
50,000 | |
| Filed 2025-07-15 22:09 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Warrants Series B Common Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-15 22:09 Tx date 2025-07-11 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
53 - Grant of warrants
|
+50,000 vol |
50,000 | |
| Filed 2025-07-15 22:08 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Warrants Series A Common Warrants
00 - Opening Balance-Initial SEDI Report
|